In a response to questions about Pfizer ending the trial of its oral drug, a company spokesperson pointed Scientific American to the press release that announced that decision and said Pfizer is working on other early-stage oral drug candidates for weight loss, including one that works on a similar hormone to GLP-1 that is currently in phase 2 clinical trials
Bostom AG, Gohh RY, Tsai MY, Hopkins-Garcia BJ, Nadeau MR, Bianchi LA, Jacques PF, Rosenberg IH, and Selhub J (1997)
This is why its only prescribed on a short-term basis
The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Glutathione with Provail therefore contains only glutathione and whey protein and the minimal ingredients required to manufacture the capsules